Sargent Bickham Lagudis LLC Albireo Pharma, Inc. Call Options Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALBO
# of Institutions
4Shares Held
865Call Options Held
0Put Options Held
0About ALBIREO PHARMA, INC.
- Ticker ALBO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,612,500
- Description
- Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...